Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications MS Dzeshka, GYH Lip, V Snezhitskiy, E Shantsila Journal of the American College of Cardiology 66 (8), 943-959, 2015 | 578 | 2015 |
Recent Advances: Atrial Fibrillation and Hypertension MS Dzeshka, A Shantsila, E Shantsila, GYH Lip Hypertension, HYPERTENSIONAHA. 117.08934, 2017 | 155 | 2017 |
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes MS Dzeshka, F Shahid, A Shantsila, GYH Lip American Journal of Hypertension, 2017 | 99 | 2017 |
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk‐Score Acronyms (CHADS2, CHA2DS2‐VASc, R2CHADS2, HAS‐BLED, ATRIA, and More) MS Dzeshka, DA Lane, GYH Lip Clinical cardiology 37 (10), 634-644, 2014 | 72 | 2014 |
Effects of aspirin on endothelial function and hypertension MS Dzeshka, A Shantsila, GYH Lip Current hypertension reports 18 (11), 1-12, 2016 | 59 | 2016 |
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation. K Senoo, YC Lau, M Dzeshka, D Lane, K Okumura, GY Lip Circulation journal: official journal of the Japanese Circulation Society, 2014 | 47 | 2014 |
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now? MS Dzeshka, GYH Lip Trends in cardiovascular medicine 25 (4), 315-336, 2015 | 33 | 2015 |
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation MS Dzeshka, GYH Lip Cardiology clinics 32 (4), 585-599, 2014 | 33 | 2014 |
Вариабельность ритма сердца: применение в кардиологии ВА Снежицкий, ВИ Шишко, ЕВ Зуховицкая, МС Дешко Учреждение образования Гродненский государственный медицинский университет, 2010 | 30 | 2010 |
Клинические аспекты гипергомоцистеинемии ВА Снежицкий, АВ Пырочкин, ВВ Спас, ЕМ Дорошенко, ТЮ Егорова, ... Гродненский государственный медицинский университет (Гродно) ББК: 54.10 УДК …, 2011 | 24 | 2011 |
Stroke And Bleeding Risk Assessment: Where Are We Now? MS Dzeshka, GYH Lip JAFIB: Journal of Atrial Fibrillation 6 (6), 2014 | 23 | 2014 |
Patients with atrial fibrillation undergoing percutaneous coronary intervention. Current concepts and concerns: part I MS Dzeshka, RA Brown, GYH Lip Polskie Archiwum Medycyny Wewnętrznej 125 (1-2), 73-81, 2015 | 18* | 2015 |
Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation MS Dzeshka, GY Lip Thromb Res 134 (2), 217-218, 2014 | 17 | 2014 |
Хронотропная функция сердца ВА Снежицкий, АВ Раков, ВИ Шишко, МС Дешко, НВ Шпак, ... Монография.–Гродно: ГрГМУ, 2011 | 14 | 2011 |
Direct oral anticoagulant reversal: how, when and issues faced MS Dzeshka, D Pastori, GYH Lip Expert Review of Hematology 10 (11), 1005-1022, 2017 | 11 | 2017 |
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation MS Dzeshka, GYH Lip Expert opinion on drug safety 14 (1), 45-62, 2015 | 11 | 2015 |
Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting MS Dzeshka, RA Brown, D Capodanno, GYH Lip Interventional Cardiology Clinics 6 (1), 91-117, 2017 | 10 | 2017 |
Некоторые биомаркеры дисфункции эндотелия и воспаления при фибрилляции предсердий МС Дешко, ВА Снежницкий Здравоохранение, 12-15, 2010 | 10 | 2010 |
P1720Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction MS Dzeshka, K Appadoo, E Shantsila, VA Snezhitskiy, GYH Lip European Heart Journal 38 (suppl_1), 2017 | 8 | 2017 |
Фибрилляция предсердий: особенности регуляции ритма сердца и транспорта кислорода кровью В Снежицкий, Е Пелеса, М Дешко Lambert Academic Publishing, 2013 | 8 | 2013 |